Ozempic (semaglutide ... agonists. (A drug class is a group of medications that work in a similar way.) Ozempic and Victoza are not approved for weight loss or weight management.

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

People are ‘microdosing’ weight-loss drugs like Ozempic. A GP explains the risks - Millions of people worldwide are now using ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

But as a doctor I am very concerned that the mad scramble to get hold of semaglutide ... before committing to weight-loss jabs. Some people are choosing to stay on a low dose permanently to ...